U.S. Venture Partners XII, L.P.
Insider CIK 1734819 · SBTX 10% owner · CARL 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CARL CARLSMED, INC. | P Buy | 2025-07-24 | 2026-09-15 | 200,000 | $15.00 | $3.00M | 200,000 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 2,948,794 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 149,655 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 825,135 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 531,877 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 26,993 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 41,876 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 1,117,743 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 825,135 | — | $0 | 3,773,929 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 531,877 | — | $0 | 4,305,806 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 149,655 | — | $0 | 149,655 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 41,876 | — | $0 | 191,531 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 26,993 | — | $0 | 218,524 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 1,117,743 | — | $0 | 1,117,743 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 2,948,794 | — | $0 | 2,948,794 | SEC↗ |
| CARL CARLSMED, INC. | P Buy | 2025-07-24 | 2026-09-15 | 200,000 | $15.00 | $3.00M | 200,000 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 54,496 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 1,073,793 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 335,417 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 6,609,027 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2020-12-08 | 2020-12-08 | 47,619 | $21.00 | $1000.0K | 47,619 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 1,779,969 | — | $0 | 1,779,969 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 289,198 | — | $0 | 2,069,167 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 90,335 | — | $0 | 90,335 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 14,677 | — | $0 | 105,012 | SEC↗ |